| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |